Related Experiment Video

Updated: Jun 29, 2026

Induction of Endothelial Differentiation in Cardiac Progenitor Cells Under Low Serum Conditions
12:48

Induction of Endothelial Differentiation in Cardiac Progenitor Cells Under Low Serum Conditions

Published on: January 7, 2019

Regenerative cell therapy and pharmacotherapeutic intervention in heart failure: Part 1: Cardiovascular progenitor

C Qian1, R G Schoemaker, W H van Gilst

  • 1Department of Experimental Cardiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.

Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation
|October 2, 2008
PubMed

Insights

Bone marrow-derived endothelial progenitor cells (BM-EPCs) are crucial for blood vessel repair. Understanding their biology and microenvironment is key to developing effective cell therapies for neovascularization and heart failure.

Area of Science:

  • Cardiovascular Biology
  • Regenerative Medicine
  • Cell Therapy

Background:

  • Endothelial progenitor cells (EPCs) from bone marrow (BM-EPCs) are implicated in neovascularization and endothelial repair.
  • Their role in pharmacological treatments and as therapeutic targets is under investigation.
  • The precise biology of EPCs and their niche microenvironments remains poorly understood.

Purpose of the Study:

  • To review the involvement of progenitor cells in chronic heart failure.
  • To focus on factors that positively influence BM-EPCs.
  • To emphasize pharmacological pathways in BM-EPC-mediated neovascularization.

Main Methods:

  • Literature review focusing on progenitor cell involvement in heart failure.
  • Analysis of factors influencing BM-EPC function.
  • Emphasis on pharmacological molecular pathways driving BM-EPC-induced neovascularization.

Main Results:

  • Progenitor cells may play a role in chronic heart failure.
  • Specific factors can beneficially affect BM-EPCs.
  • Pharmacological pathways are crucial for BM-EPC-mediated neovascularization.

Conclusions:

  • A deeper understanding of EPC biology and niche signaling is essential for successful angiogenic cell therapy.
  • Rational pharmacotherapy targeting BM-EPCs can enhance vascular repair.
  • Optimizing BM-EPC function is critical for clinical improvement in vascular repair and angiogenic therapies.

Keywords:
angiogenesisbone marrow derived stem cellsendothelial progenitor cellsheart failure

More Related Videos

Generation of Aligned Functional Myocardial Tissue Through Microcontact Printing11:09

Generation of Aligned Functional Myocardial Tissue Through Microcontact Printing

Published on: March 19, 2013

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy10:16

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Published on: January 25, 2019

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...